Bayer sees improvement in 2026 after profit decline this year
Published by Global Banking & Finance Review®
Posted on March 5, 2025
1 min readLast updated: January 25, 2026
Published by Global Banking & Finance Review®
Posted on March 5, 2025
1 min readLast updated: January 25, 2026
Bayer projects a challenging 2025 with flat sales and lower cash flow, but expects financial improvement starting in 2026.
FRANKFURT (Reuters) - Bayer on Wednesday raised the prospect of a return to earnings growth next year after reiterating that a decline was expected for this year.
In a statement, the German maker of drugs and farming pesticides said 2025 would be "the most difficult in terms of financial performance, with net sales roughly in line with and earnings and free cash flow behind the prior year".
"The company expects improved performance from 2026 onwards," it added.
(Reporting by Ludwig Burger, Editing by Miranda Murray)
The main topic is Bayer's financial forecast, highlighting expected profit decline in 2025 and growth from 2026.
Bayer anticipates 2025 to be financially challenging with flat net sales and reduced free cash flow.
Bayer expects financial performance to improve from 2026 onwards.
Explore more articles in the Finance category
